Skip to main content
Log in

Entecavir

Development of resistance in chronic hepatitis B virus infection: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yap DYH, et al. Long-term data on entecavir treatment for treatment-naive or lamivudine-resistant chronic hepatitis B infection in kidney transplant recipients. Transplant Infectious Disease 21: No. 5, Oct 2019. Available from: URL: http://doi.org/10.1111/tid.13143 - Hong Kong

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Entecavir. Reactions Weekly 1782, 138 (2019). https://doi.org/10.1007/s40278-019-72307-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-72307-0

Navigation